Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: Investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase

Biochemical Journal

Volumn 388, Issue 1, 2005, Pages 205-215

  Ferry, Gilles ^a   Ubeaud, Caroline ^a   Lambert, Pierre Hervé ^b   Bertin, Sophie ^b   Cogé, Francis ^a   Chomarat, Pascale ^a   Delagrange, Philippe ^a   Serkiz, Bernard ^b   Bouchet, Jean Paul ^b   Truscott, Roger J W ^c   Boutin, Jean A ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Indole ring; Indoleamine 2,3 dioxygenase; Kynurenine; Melatonin; Myeloperoxidase; Oxidative catabolism

Indexed keywords

CATABOLISM; INDOLEAMINES; MELATONIN; PHARMACOLOGY;

AMINES; ENZYMES; ESCHERICHIA COLI; METABOLISM; OXIDATION;

BIOCHEMISTRY;

INDOLE DERIVATIVE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; MELATONIN; MYELOPEROXIDASE; PEROXIDASE; SEROTONIN; TRYPTAMINE; TRYPTOPHAN;

AEROBIC METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME PURIFICATION; ENZYME SPECIFICITY; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MELATONIN; MODELS, CHEMICAL; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PEROXIDASE; SUBSTRATE SPECIFICITY; TRYPTOPHAN;

ESCHERICHIA COLI;

EID: 21144451785     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20042075     Document Type: Article

References (51)

1. Delagrange, P., Atkinson, J., Boutin, J. A., Casteilla, L. Lesieur, D., Misslin, R., Pellissier, S., Penicaud, L. and Renard, P. (2003) Therapeutic perspectives for melatonin agonists and antagonists. J. Neuroendocrinol. 15, 442-448
2. Reference deleted
3. Axelrod, J. (1974) The pineal gland: a neurochemical transducer. Science 184, 1341-1348
4. Klein, D. C., Coon, S. L., Roseboom, P. H., Weller, J. L., Bernard, M., Gastel, J. A., Zatz, M., Iuvone, P. M., Rodriguez, I. R., Begay, V. et al. (1997) The melatonin rhythm-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Recent Prog. Horm. Res. 52, 482-510
5. Leone, A. M., Francis, P. L. and Silma, R. E. (1987) The isolation, purification, and characterisation of the principal urinary metabolites of melatonin. J. Pineal Res. 4, 253-266
6. Ishimura, Y., Nozaki, M. and Jhayaishi, O. (1970) The oxygenated form of L-tryptophan-2,3-dioxygenase as reaction intermediate. J. Biol. Chem. 245, 3593-3602
7. Hirata, F., Hayaishi, O., Tokuyama, T. and Senoh, S. (1974) In vitro and in vivo formation of two new metabolites of melatcnin. J. Biol. Chem. 249, 1311-1313
8. Takikawa, O., Yoshida, R. and Hayaishi O. (1983) Monooxygenase activities of dioxygenases. Benzphetarnine demethylation and aniline hydroxylation reactions catalyzed by indoleamine 2,3-dioxygenase. J. Biol. Chem. 258, 6808-6815
9. Shimizu, T., Nomiyama, S., Hirata, F. and Hayaishi, O. (1978) Indoleamine 2,3-dioxygenase. Purification and some properties. J. Biol. Chem. 253, 4700-4706
10. Silva, S. O., Ximenes, V. F., Catalani, L. H. and Campa, A. (2000) Myeloperoxidase-catalyzed oxidation of melatonin by activated neutrophils. Biochem. Biophys. Res. Commun. 279, 657-662
11. Allegra, M., Furtmüller, P. G., Regelsberger, G., Turco-Liveri, M. L., Tesoriere, L., Perretti, M.. Livrea, M. A. and Obinger, C. (2001) Mechanism of reaction of melatonin with human myeloperoxidase. Biochem. Biophys. Res. Commun. 282, 380-386
12. Littlejohn, T. K., Takikawa, O., Skylas, D., Jamie, J. F., Walker, M. J. and Truscott, R. J. W. (2000) Expression and purification of recombinant human indoleamine 2,3-dioxygenase. Protein Expr. Purif. 19, 22-29
13. Terentis, A. C., Thomas, S R., Takikswa, O., Littlejohn, T. K., Truscott, R. J. W., Armstrong, R. S., Yeh, S. R. and Stocker, R. (2002) The heme environment of recombinant human indoleamine 2,3-dioxygenase. Structural properties and substrate-ligand interactions. J. Biol. Chem. 277, 15788-15794
14. Southan, M. D., Truscott, R. J. W., Jamie, J. F., Pelosi, L., Walker, M. J., Maeda, H., Iwamoto, Y. and Tone, S. (1996) Structural requirements of the competitive binding site of recombinant human indoleamine 2,3-dioxygenase. Med. Chem. Res. 6, 343-352
15. Austin, C. J., Mizdrak, J., Matin, A., Sirijovski, N., Kosim-Satyaputra, P., Willows, R. D., Robert, T. H., Truscott, R. J., Polekina, G., Parker, M. W. and Jamie, J. F. (2004) Optimised expression and purification of recombinant human indoleamine-2,3-dioxygenase. Protein Exp. Purif. 37, 392-398
16. Ohnishi, T., Hirata, F. and Hayaishi, O. (1977) Indoleamine-2 3-dioxygenase. Potassium Superoxide as substrate. J. Biol. Chem. 252, 4643-4647
17. Grohmann, U., Fallarino, F. and Puccetti, P. (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 24, 242-248
18. Ferry, G., Loynet, A., Kucharczyk, N., Bertin, S., Rodriguez, M., Delagrange, P., Galizzi, J. P., Jacoby, E., Volland, J. P., Lesieur, D. et al. (2000) Substrate specificity and inhibition studies of human serotonin N-acetyltransferase. J. Biol. Chem. 275, 8794-8805
19. Ferry, G., Mozo, J., Ubeaud, C., Berger, S., Bertrand, M., Try, A., Beauverger, P., Mesangeau, C., Delagrange, P. and Boutin, J. A. (2002) Characterization and regulation of a CHO cell line stably expressing the human serotonin N-acetyltransferase (EC 2.3.1.87). Cell. Mol. Life Sci. 59, 1395-1405
20. Ferry, G., Ubeaud, C., Mozo, J., Péan, C., Hennig, P., Rodriguez, M., Seoul, C., Bonnaud, A., Nosjean, O., Galizzi, J. P. et al. (2004) New substrate analogues of human serotonin N-acetyltransferase produce in situ specific and potent inhibitors. Eur. J. Biocnem. 271, 418-428
21. Ferry, G., Ubeaud, C., Dauly, C., Mozo, J., Guillard, S., Berger, S., Jimenez, S., Scoul, C., Leclerc, G., Delagrange, P. and Boutin, J. A. (2004) Further attempts to purify human serotonin N-acetyltransferase (EC 2.3.1,87). Comparison with other species and implication for its enzymatic behavior. Protein Expr. Purif. 38, 84-98
22. Nosjean, O., Ferro, M., Coge, F., Beauverger, P., Henlin, J. M., Lefoulon, F., Fauchere, J. L., Delagrange, P., Canet, E. and Boutin, J. A. (2000) Identification of the melatonin binding site MT3 as the quinone reductase 2. J. Biol. Chem. 275, 31311-31317
23. Nosjean, O., Nicolas, J. P., Klupsch, F., Delagrange, P., Canet, E. and Boutin, J. A. (2001) Comparative pharmacological studies at the melatonin receptors MT1, MT2 and MT3/QR2. Biochem. Pharmacol. 61, 1369-1379
24. 2 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 367, 553-561
25. 2. Biochem. Pharmacol. 67, 667-677
26. Yamamoto, S. and Hayaishi, O. (1967) Tryptophan pyrrolase of rabbit intestine. D- and L-tryptophan-cleaving enzyme or enzymes. J. Biol. Chem. 242, 5260-5266
27. Segel, I. H. (1975) Enzyme Kinetics, John Wiley & Sons, New York
28. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227, 680-685
29. Cady, S. and Sono, M. (1991) 1-Methyl-DL-tryptophan, beta-(3- benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and oeta-[3-benzo(b)thieny]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch. Biochem. Biophys. 291, 326-333
30. Yamazaki, F., Kuroiwa, T., Takikawa, O. and Kido, R. (1985) Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem. J. 230, 635-638
31. Schultz, J., Corlin, R., Oddi, F., Kaminker, K. and Jones, W. (1965) Myeloperoxidase of the leucocyte of normal human blood. 3. Iso alien of the peroxidase granule. Arch. Biochem. Biophys. 111, 73-79
32. Bos, A., Wever, R. and Roos, D. (1978) Characterization and quantification of the peroxidase in human monocytes. Biochim. Bioptiys. Acta 525, 37-44
33. Rodrigues, M. R., Rodriguez, D., Catalani, L. H., Russo, M. and Campa, A. (2002) Macrophage activation includes high intracellular myeloperoxidase activity. Biochem. Biophys. Res. Commun. 292, 869-873
34. Rodrigues, M. R., Rodrigue, D., Catalani, L. H., Russo, M. and Campa, A. (2003) Interferon-gamma independent oxidation of melatonin by macrophages. J. Pineal Res. 34, 69-74
35. Andrews, P. C. and Krinsky, N. I. (1986) Human myeloperoxidase and hemimyeloperoxidase. Methods Enzymol. 132, 369-378
36. Ghibaudi, E. and Laurenti, E. (2003) Unraveling the catalytic mechanism of lactoperoxidase and myeloperoxidase. Eur. J. Biochem. 270, 4403-4412
37. Reference deleted
38. Kopin, I. J., Pare, C. M. B., Axelrod, J. and Weissbach, H. (1960) 6-Hydroxylation, the major metabolic pathway for melatonin. Biochim. Biophys. Acta 40, 377-378
39. Kopin, I. J., Pare, C. M. B., Axelrod, J. and Weissbach, H. (1961) The fate of melatonin in animals. J. Biol. Chem. 236, 3072-3075
40. Hardeland, R. and Fuhrberg, B. (1996) Ubiquitous melatonin - Presence and effects in unicells, plants and animals. Trends Comp. Biochem. Physiol. 2, 25-45
41. Hardeland, R., Coto-Montes, A. and Fuhrberg, B. (2003) Circadian rhythms, oxidative stress, and antioxidotive defense mechanisms. Chronobiol. Int. 20, 921-962
42. Carlin, J. M., Ozaki, Y., Byrne, G. I., Brown, R. R. and Borden, E. C. (1989) Interferons and indoleamine 2,3-dioxygenase role in antimicrobial and antitumor effects. Experientia 45, 533-541
43. Tan, D. X., Manchester, L. C., Reiter, R. J., Qi, W., Zhang, M., Weintraub, S. T., Cabrera, J., Sainz, R. M. and Mayo, J. C. (1999) Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biaphys. Acta 1472, 206-214
44. Yoshida, R., Imanishi, J., Out, T., Kishida, T. and Hayaishi, O. (1981) Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc. Natl. Acad. Sci. U.S.A. 78, 129-132
45. Fujiwara, M., Shibata, M., Watanabe, Y., Nukiwa, T., Hirata, F., Mizuno, M. and Hayaishi, O. (1978) Indoleamine 2,3-dioxygenase. Formation of L-kynurenine from L-tryptophan in cultured rabbit fineal gland. J. Biol Chem. 253, 6081-6085
46. Ximenes, V. F., Catalani, L. H. and Campa, A. (2001) Oxidation of melatonin and tryptophan by an HRP cycle involving compound III. Biochem. Biophys. Res. Commun. 287, 130-134
47. Tan, D. X., Manchester, L. C., Burkhardt, S., Sainz, R. M., Mayo, J. C., Kohen, R., Shchami, E., Huo, Y. S., Hardeland, R. and Reiter, R. J. (2001) N1-acetyl-N2-fomyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 15, 2294-2296
48. Rozov, S. V., Filatova, E. V. Orlov, A. A., Volkova, A. V., Zhloba, A. R. A., Blashko, E. L. and Pozdeyevn, N. V. (2003) N1-acetyl-N2-fotmyl-5- methoxykynuramine is a product of melatonin oxidation in rats. J. Pineal Res 35, 245-250
49. Harthe, C., Claudy D., Dechaud, H., Vivien-Roels, B., Pevet, P. and Claustrat, B. (2003) Radioimmunoassay of N-acetyl-N-formyl-5-methoxykynuramine (AFMK): a metatonin oxidative metabolite. Life Sci. 73, 1587-1597
50. Stone, T. W. (2001) Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol. 64, 185-218
51. Walsh, H. A. and Daya, S. (1997) Inhibition of hepatic tryptophan-2,3-dioxygenase: superior potency of melatonin over serotonin. J. Pineal Res. 23, 20-23